Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.50 is 23% below its 4-year average of 5.82, around the middle of its 4-year range (0.00–7.56).
As of the fiscal period ended Tuesday, June 30, 2026. 27.18% below its 12-month average of 6.19.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.50.
CURRENT RATIO
4.50
CURRENT RATIO AVG TTM
6.19
CURRENT RATIO AVG 3Y
5.68
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-27.18%
CURRENT VS 3Y AVG
-20.74%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+19.80%
vs the sector median at left
Metagenomi, Inc. Common Stock
Market Cap
$38.78M
Current Ratio
4.50
TTM Avg
6.19
3Y Avg
5.68
5Y Avg
N/A
Market Cap
$37.93M
Current Ratio
48.81
TTM Avg
25.84
3Y Avg
15.89
5Y Avg
15.79
Market Cap
$36.21M
Current Ratio
0.18
TTM Avg
0.18
3Y Avg
0.32
5Y Avg
0.43
Market Cap
$35.84M
Current Ratio
2.77
TTM Avg
2.09
3Y Avg
1.85
5Y Avg
2.65
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Metagenomi, Inc. Common Stock (MGX) | $38.78M | 4.50 | 6.19 | 5.68 | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.61M | 1.87 | 1.51 | 1.77 | 1.99 |
| Incannex Healthcare Limited (IXHL)vs › | $37.93M | 48.81 | 25.84 | 15.89 | 15.79 |
| Veru Inc. (VERU)vs › | $39.64M | 4.42 | 2.70 | 2.35 | 3.47 |
| EUDA Health Holdings Limited (EUDA)vs › | $36.21M | 0.18 | 0.18 | 0.32 | 0.43 |
| Elicio Therapeutics, Inc. (ELTX)vs › | $35.84M | 2.77 | 2.09 | 1.85 | 2.65 |
| Edesa Biotech, Inc. (EDSA)vs › | $35.84M | 2.76 | 5.79 | 4.84 | 5.49 |
| DocGo Inc. (DCGO)vs › | $35.76M | 1.66 | 2.38 | 2.37 | 2.73 |
| Precipio, Inc. (PRPO)vs › | $41.83M | 1.77 | 1.21 | 1.23 | 1.50 |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | 0.98 | 2.74 | 1.63 | 1.13 |
Current Ratio
4.50
Quick Ratio
4.50
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 4.50 |
| 2026-03-31 | 6.43 |
| 2025-12-31 | 7.22 |
| 2025-09-30 | 6.42 |
| 2025-06-30 | 6.36 |
| 2025-03-31 | 5.85 |
| 2024-12-31 | 6.91 |
| 2024-09-30 | 6.18 |
| 2024-06-30 | 5.82 |
| 2024-03-31 | 4.75 |
| 2023-12-31 | 4.04 |
| 2023-09-30 | 4.36 |
| 2023-06-30 | 5.04 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 7.56 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
